Stein, Isidore; Katabi, Ghazi
May 1962
Angiology;May1962, Vol. 13 Issue 5, p212
Academic Journal
The article presents a discussion related to the use of a new diuretic polythiazide in congestive failure and hypertension. A. series of patients was studied to observe the effect of a new thiazide on their signs of congestive failure and another group with hypertension. Of 17 patients with congestive failure, 16 showed good or fair results. One patient was not helped. Eight of the patients with hypertension showed a definite lowering of their pressure. Four others who were also decompensated did well. It is concluded that polythiazide is a potent diuretic and hypotensive agent in doses of 2 to 4 mg a day, with no distressing side-effects.


Related Articles

  • Patterns of antihypertensive therapy in new users of angiotensin II-receptor blockers. Young, Christopher H.; Zhang, Kui; Poret, Amy W. // American Journal of Health-System Pharmacy;11/15/2005, Vol. 62 Issue 22, p2381 

    Purpose. The patterns of angiotensin II-receptor blocker (ARB) therapy in patients with and without a history of antihypertensive use were studied. Methods. Data for this retrospective cohort study were obtained from Caremark's data warehouse. Patients were included in the analysis if they...

  • ACETAZOLAMIDE ALONE AND IN COMBINATION WITH RESERPINE IN THE TREATMENT OF HYPERTENSION. Brest, Albert N.; Onesti, Gaddo; Sekine, George; Kodama, Ryuichi; Moyer, John H. // Angiology;Nov1961, Vol. 12 Issue 11, p589 

    Acetazolamide used alone produced a minor antihypertensive effect. Although the addition of reserpine enhanced the hypotensive response, the therapeutic combination of acetazolamide and reserpine appears to be less effective than combined thiazide-Rauwolfia regimens. The antihypertensive...

  • GUANETHIDINE AND HYPERTENSION AFTER FIVE YEARS. Leishman, A. W. D.; Oxon, D. M.; Sandler, G. // Angiology;Nov1967, Vol. 18 Issue 11, p705 

    The progress of 224 hypertensive patients (112 male; 112 female) treated with guanethidine for 1 to 5½ years is reported. The daily dose of guanethidine has varied from 10 to 200 mg. Fewer than half the patients have required a diuretic drug in addition. One third of the patients required a...

  • Renal and hemodynamic responses to bumetanide in hypertension: Effects of nitrendipine. Wilcox, Christopher S.; Loon, Nicholas R.; Ameer, Barbara; Limacher, Marian C. // Kidney International;Oct1989, Vol. 36 Issue 4, p719 

    The effects of a calcium antagonist on the response to a loop diuretic were tested in eight hypertensive patients while they received 120 mmol · 24 hr-1 of dietary Na. Nitrendipine (N; 20 mg) or placebo (P) was administered twice daily for five days and bumetanide (B; 1 mg i.v.) for the last...

  • Prescribing for uncomplicated hypertension. Cox, Bev // Practice Nurse;10/24/2008, Vol. 36 Issue 7, p25 

    The article explains the basic pathophysiology of raised blood pressure, and presents case studies to demonstrate how to effectively implement the guidelines in the treatment of patients with uncomplicated hypertension. In patients with hypertension who are over 55 years old, more initial...

  • Design of a Genetically Modified Soybean Protein Preventing Hypertension Based on an Anti-Hypertensive Peptide Derived from Ovalbumin. Matoba, N.; Yamada, Y.; Yoshikawa, M. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Jun2003, Vol. 1 Issue 2, p197 

    Food proteins can be a source of various bioactive peptides including such possessing anti-hypertensive activity. While most orally active anti-hypertensive peptides derived from food proteins inhibit the angiotensin Iconverting enzyme (ACE), ovokinin (2-7) (RADHPF), a peptide isolated from a...

  • New combination.  // Formulary;Dec2009, Vol. 44 Issue 12, p355 

    The article reports that a combination of Telmisartan, an angiotensin II receptor blocker (ARB) and amiodipine, a dihydropyridine calcium channel blocker (DHP-CCB) tablets have been approved for hypertension treatment. It states that it can be given alone or in combination with other...

  • The Appropriate Goals of Antihypertensive Therapy: Neither Too Much Nor Too Little. Kaplan, Norman M. // Annals of Internal Medicine;4/15/92, Vol. 116 Issue 8, p686 

    Discusses the management of hypertensive patients. Reasons for undertreatment of hypertension; Reasons for overtreatment of the disease; Problems encountered with antihypertensive drugs.

  • Hypertension and Counter-Hypertension Mechanisms in Giraffes. Qiong Gus Zhang // Cardiovascular & Haematological Disorders - Drug Targets;Mar2006, Vol. 6 Issue 1, p63 

    The giraffe is unique as its head is 2500-3000 millimeters above its heart, thus the giraffe's heart must pump hard enough to overcome the huge hydrostatic pressure generated by the tall column of blood in its neck in order to provide its head with sufficient nutrients and oxygen. Giraffes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics